Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Growth Paris  >  Cellectis    ALCLS   FR0010425595

CELLECTIS

(ALCLS)
  Report
Real-time Quote. Real-time Euronext Growth Paris - 01/25 03:21:23 am
25.55 EUR   -1.16%
01/20European ADRs Edge Lower in Wednesday Trading
MT
01/19European ADRs Move Higher in Tuesday Trading
MT
01/14European ADRs Climb Higher in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on CELLECTIS
03/15/21 Esercizio 2020 Pubblicazione dei risultati (proiezione)
05/12/21 Q1 2021 Pubblicazione dei risultati (proiezione)
08/04/21 Primo semestre 2021 Pubblicazione dei risultati (proiezione)
11/23/21 Q3 2021 Pubblicazione dei risultati (proiezione)
Past events on CELLECTIS
12/05/20 | 10:00pm American Society of Hematology Meeting - Abstract No - 163#
12/05/20 American Society of Hematology Meeting - Abstract No - 1039#
11/06/20 | 02:00pm Q3 2020 Presentazione dei risultati
11/05/20 | 10:34pm Q3 2020 Pubblicazione dei risultati
Upcoming sector events for CELLECTIS
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for CELLECTIS
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/20/21 | 01:00pm IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M €
Released
Forecast
Spread
56,4
29,8
89%
51,0
46,8
9,1%
27,4
31,3
-12%
19,1
21,7
-12%
20,6
19,7
4,8%

53,4
Operating income
(EBITDA)
M €
Released
Forecast
Spread
-26,2
-20,7
-26%
-58,8

-72,0

-91,0
-92,0
1,1%
-104
-96,6
-8,0%

-75,7
Operating profit
(EBIT)
M €
Released
Forecast
Spread
-27,9
-34,5
19%
-60,8
-59,9
-1,5%
-75,2
-79,8
5,7%
-93,6
-93,0
-0,59%
-111
-108
-2,6%

-75,3
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
-20,4
-42,6
52%
-60,8
-61,2
0,72%
-84,2
-88,5
4,9%
-78,7
-83,5
5,9%
-103
-99,1
-4,5%

-76,2
Net income
M €
Released
Forecast
Spread
-20,5
-26,1
21%
-60,8
-63,9
4,9%
-80,7
-86,7
6,9%
-70,1
-79,0
11%
-91,7
-95,2
3,7%

-74,3
EPS
Released
Forecast
Spread
-0,60
0,04
-1 600%
-1,72

-2,26
-2,14
-5,6%
-1,71
-2,61
35%
-2,16
-3,17
32%

-2,75
Announcement Date03/14/201603/06/201703/12/201803/11/201903/04/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M €
Released
Forecast
Spread
9,22
3,17
190%
5,69
3,90
46%
48,1
13,8
248%
3,88
4,51
-14%
7,81
11,6
-33%

6,16
Operating income
(EBITDA)
M €
Released
Forecast
Spread
-24,1
-31,8
24%
-34,6
-32,0
-8,0%
13,3
-23,4
157%
-27,8
-31,9
13%
-24,8
-32,6
24%

-28,4
Operating profit
(EBIT)
M €
Released
Forecast
Spread
-17,6
-31,2
44%
-37,0
-33,3
-11%
15,4
-20,5
175%
-30,1
-33,0
8,7%
-28,4
-33,0
14%

-30,3
Pre-Tax Profit
(EBT)
M €
Released
Forecast
Spread
-14,5
-30,6
53%
-33,4
-31,5
-6,0%
18,6
-25,7
172%
-27,1
-28,8
6,0%
-25,6
-29,7
14%

-33,0
Announcement Date11/06/201903/04/202005/06/202008/05/202011/05/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise